NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) Chart & Stock Price History $30.59 +0.66 (+2.21%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock NYLI Candriam U.S. Mid Cap Equity ETF Stock Price Performance 5 Day Performance+2.86%1 Month Performance+4.65%3 Month Performance-8.28%6 Month Performance-6.41%Year-To-Date Performance-5.76%1 Year Performance+0.66% Receive IQSM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NYLI Candriam U.S. Mid Cap Equity ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IQSM Stock Chart for Saturday, May, 3, 2025 IQSM Chart by TradingView NYLI Candriam U.S. Mid Cap Equity ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$29.93$30.59+2.21%$30.59$30.5941 shs$203.42 million05/01/2025$29.84$29.93+0.30%$30.01$29.93886 shs$199.03 million04/30/2025$29.85$29.84-0.03%$29.84$29.8440 shs$198.44 million04/29/2025$29.74$29.85+0.37%$29.85$29.8583 shs$198.50 million04/28/2025$29.58$29.74+0.54%$29.74$29.7470 shs$197.77 million04/25/2025$29.61$29.58-0.10%$29.58$29.5845 shs$196.71 million04/24/2025$29.04$29.61+1.96%$29.61$29.6156 shs$196.91 million04/23/2025$28.57$29.04+1.65%$29.04$29.04150 shs$193.12 million04/22/2025$27.82$28.57+2.70%$28.57$28.39802 shs$189.99 million04/21/2025$28.47$27.82-2.28%$28.00$27.82175 shs$185.00 million Get the Latest News and Ratings for IQSM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NYLI Candriam U.S. Mid Cap Equity ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$28.47$28.47$28.47$28.47112 shs$189.33 million04/17/2025$28.29$28.47+0.64%$28.47$28.47112 shs$189.33 million04/16/2025$28.68$28.29-1.36%$28.29$28.29133 shs$188.13 million04/15/2025$28.75$28.68-0.24%$28.68$28.68175 shs$190.72 million04/14/2025$28.38$28.75+1.30%$28.75$28.62401 shs$191.19 million04/11/2025$27.98$28.38+1.43%$28.41$27.80577 shs$188.73 million04/10/2025$29.23$27.98-4.28%$27.98$27.98200 shs$186.07 million04/09/2025$26.80$29.23+9.07%$29.32$27.09947 shs$194.38 million04/09/2025$26.80$29.23+9.07%$29.32$27.09947 shs$194.38 million04/08/2025$27.48$26.80-2.47%$27.19$26.782,383 shs$178.22 million04/08/2025$27.48$26.80-2.47%$27.19$26.782,383 shs$178.22 million04/07/2025$27.78$27.48-1.08%$27.48$27.341,387 shs$182.74 million04/04/2025$29.23$27.78-4.96%$27.79$27.79363 shs$184.74 million04/03/2025$31.14$29.23-6.13%$29.46$29.23357 shs$194.38 million04/02/2025$30.68$31.14+1.50%$31.14$30.97413 shs$207.08 million Related Companies First Trust Mid Cap Value AlphaDEX Fund Stock Price Chart Invesco Zacks Mid-Cap ETF Stock Price Chart Avantis U.S. Mid Cap Value ETF Stock Price Chart Invesco S&P MidCap 400 Pure Value ETF Stock Price Chart Invesco S&P MidCap Value with Momentum ETF Stock Price Chart Avantis U.S. Mid Cap Equity ETF Stock Price Chart WisdomTree International MidCap Dividend Fund Stock Price Chart Invesco S&P MidCap 400 Pure Growth ETF Stock Price Chart ProShares Ultra MidCap 400 Stock Price Chart Argent Mid Cap ETF Stock Price Chart Receive IQSM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NYLI Candriam U.S. Mid Cap Equity ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:IQSM) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NYLI Candriam U.S. Mid Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share NYLI Candriam U.S. Mid Cap Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
